Results 241 to 250 of about 243,161 (291)

Outline of the History of U.S. Drug Regulation and Labeling

, 1981
Janssen, Wallace F.
core  

A Fivefold Maximum Drug-Likeness Strategy for Prioritizing Antibacterial Candidates Against <i>Escherichia coli</i>. [PDF]

Pharmaceuticals (Basel)
Zhu H, Du S, Yang Q, Xu L, Shi W.
europepmc   +1 more source

[ON DRUG LABELING].

Farmatsevtychnyi zhurnal, 1996
openaire   +1 more source

Mu Opioid Receptor mRNA and Protein Localization Across the Rat and Mouse Habenula. [PDF]

J Comp Neurol
Popat AK, Simon RC, Aoyama BB, Wokhlu A, Ehrlich AT, Harwell CC, Margolis EB.   +6 more
europepmc   +1 more source

Peripheral nervous system safety signals of antibody-drug conjugates: cross-database reproducibility and labeling gaps identified using FAERS, JADER, and CVARD. [PDF]

Front Pharmacol
Feng X, Qin Y, Ma H, Feng R, Huo L.
europepmc   +1 more source

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Blood
Himonas E, de Beauchamp L, Zerbst D, Desmares-Romain E, Sarnello D, Kalkman ER, Rattigan KM, James D, Shokry E, Copland M, Griessinger E, Récher C, De Mas V, Vergez F, Sumpton D, Schimmer AD, Minden MD, Gottlieb E, Shanks E, Sarry JE, Helgason GV.   +20 more
europepmc   +1 more source